List view / Grid view

multiple myeloma



Takeda to enrol 5000 patients in giant multiple myeloma trial

1 September 2016 | By Niamh Louise Marriott, Digital Content Producer

Takeda’s global non-interventional, observational multiple myeloma study is now enrolling patients, aiming to have 5,000 patients over three years with a goal of following each patient for a minimum of five years in an effort to track patterns in disease presentation, patient characteristics, treatment and outcomes, thereby enhancing the understanding…